The global foot and mouth disease (FMD) vaccine market is
expected to reach USD 3.0 billion by 2025, according to a new report by Grand
View Research, Inc. Increase in incidence of FMD and their socioeconomic impact
over international trade of animal products are propelling the demand for FMD
vaccines. In addition, effectiveness for lower time period propels repeat purchase
of vaccines.
This market is highly competitive
and various government entities intervene for bulk purchase of vaccines. There
has been a dynamic growth in the global livestock population over the past few
decades. In developing countries, the demand for livestock products is
increasing owing to which concern for healthy livestock population is
increasing.Rising demand for animal products has revolutionized the global
livestock production. In addition, factors such as change in food preferences
owing to changing lifestyle coupled with growing population are anticipated to
boost the demand for livestock products.
Increased adoption of oil-based
vaccines owing to their higher efficacy is expected to contribute to the
largest share of conventional vaccines. Available conventional vaccines are
effective in the prevention of clinical diseases; however, they offer
protection for a shorter duration. Hence, as a prophylactic measure, frequent
vaccination becomes necessary.
Browse full research report on Global
Foot & Mouth Disease Vaccine Market: http://www.grandviewresearch.com/industry-analysis/foot-mouth-disease-fmd-vaccine-market
Further Key Findings from the Report:
- Conventional vaccines emerged as the largest segment because of increasing approvals of vaccines and higher efficacy
- The cattle segment accounted for the largest share in the animal type segment owing to increase in domestic livestock population and number of outbreaks
- Sheep and Goat segment is expected to grow at the fastest rate over the forecast period owing to rising incidence of FMD infection in sheep population and the need for reducing slaughter of infected animals.
- Asia Pacific dominated the market with the largest share in 2016. Rise in incidence of FMD and increase in demand for livestock products are facilitating dominance of the region during the forecast period.
- Key players including Agrovet Co.; Biogénesis Bago; Empresa Colombiana de Productos Veterinarios S.A. Vecol S.A.; FGBI - Federal Centre for Animal Health ; Indian Immunologicals Limited ; Merial (France); Veterinary Serum and Vaccine Research Institute; FMD Center; and Limor de Colombia are leading the global FMD vaccine market.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global foot and mouth
disease vaccine market based on technique, animal type, and region:
Technique Outlook (Revenue, USD Million, 2014 - 2025)
- Conventional vaccines
- Aluminum hydroxide/Saponin-based vaccines
- Oil-based vaccines
- Emergency vaccines
Animal Type Outlook (Revenue, USD Million, 2014 - 2025)
- Cattle
- Sheep and Goat
- Pigs
- Others (antelope, deer, bison, camelids)
Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- Europe
- Asia Pacific
- India
- China
- Japan
- Malaysia
- South Korea
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Nigeria
- Saudi Arabia
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment